Agenus (AGEN) EPS (Diluted) Growth (3y) (2014 - 2026)
Agenus (AGEN) EPS (Diluted) Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 78.99% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 37.28% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.39% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -2.00% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 83.94% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Agenus | 184.05 Mn | 177.29 Mn | 33.74 Mn | 26.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.00% |
| Dec 31, 2025 | 95.86% |
| Sep 30, 2025 | 26.00% |
| Jun 30, 2025 | 93.33% |
| Mar 31, 2025 | 93.49% |
| Dec 31, 2024 | 92.80% |
| Sep 30, 2024 | -26.00% |
| Jun 30, 2024 | 93.04% |
| Mar 31, 2024 | 92.13% |
| Dec 31, 2023 | 15.98% |
| Sep 30, 2023 | 16.26% |
| Jun 30, 2023 | 15.66% |
| Mar 31, 2023 | 11.27% |
| Dec 31, 2022 | -7.62% |
| Sep 30, 2022 | 14.84% |
| Jun 30, 2022 | 21.06% |
| Mar 31, 2022 | -51.95% |
| Dec 31, 2021 | 14.98% |
| Sep 30, 2021 | 61.81% |
| Jun 30, 2021 | -15.76% |